P/B
1,5
Addex Therapeutics
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
$6.1M
Market Cap • 9/22/2026
2007
(19 years)
Founded
2020
(6 years ago)
IPO
NASDAQ
Listing Exchange
Switzerland
Country
Valuation
P/S
44,3
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
4,4
EPS
—
Market Cap
Market Cap
6,1M
EV
5,1M
EV/Revenue
36,7
EV/EBITDA
-1,5
EV/EBIT
-1,5
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-50%
Total Yield
-50%
Payout
0%
Retained Earnings
-453,5M
Profitability
Gross Margin
100%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
503,4%
Capex/Revenue
0%
Capex/D&A
0%
Capex/OCF
0%
SBC/OCF
—
% PPE
2,1%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
-49,5%
CAGR Op. Income 5Y
-22,6%
CAGR Net Income 5Y
-6,3%
CAGR EPS 5Y
-32,2%
CAGR OCF 5Y
-24,3%
Leverage
N.D./EBITDA
0,3
Debt/Equity
0%
Current Ratio
1
Quick Ratio
0,8
Interest Coverage
294273%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!